Comparative meta-analysis of complications in implantable port catheters versus peripherally inserted central catheters in chemotherapy-treated cancer patients

Background and objectives: A meta-analysis compared complications associated with Peripherally Inserted Central Catheters (PICCs) and Implanted Port Catheters (IPCs) in cancer patients undergoing chemotherapy. Methods: A comprehensive literature search up to December 2024, involving 12,587 participants, was analyzed using pooled Odds Ratios (ORs) and Mean Differences (MDs) with 95% Confidence Intervals (CIs). Dichotomous and continuous outcome measures were evaluated via random-effects or fixed-effects models. Results: Results revealed that PICC use was linked to significantly elevated risks of occlusion (OR 4.39; 95% CI 2.95-6.52, p<0.001), catheter-related infections (OR 2.42; 95% CI 1.34-4.36, p=0.003), malposition (OR 7.39; 95% CI 3.52-15.50, p><0.001), thrombosis (OR 2.88; 95% CI 2.05-4.05, p><0.001), phlebitis (OR 6.41; 95% CI 2.90-14.14, p><0.001), and accidental removal (OR 3.38; 95% > <0.001), catheter-related infections (OR 2.42; 95% CI 1.34-4.36, p=0.003), malposition (OR 7.39; 95% CI 3.52-15.50, p<0.001), > <0.001), thrombosis (OR 2.88; 95% CI 2.05-4.05, p<0.001), phlebitis (OR 6.41; 95% CI 2.90-14.14, p<0.001), and accidental removal (OR 3.38; 95% CI 1.97-5.81, p<0.001), alongside a notably shorter indwelling duration (MD -233.16 days; 95% CI -449.52 to -16.80, p=0.03) compared to IPC. However, no significant differences were found in puncture-site local infection rates (OR 1.79; 95% CI 0.88-3.64, p=0.11) or cost (MD -394.02; 95% CI -882.19 to 94.14, p=0.11) between the two devices. Conclusion: Patients with PICCs experienced significantly more complications than those with IPCs, especially cancer patients undergoing chemotherapy. These complications included occlusions, catheter-related infections, malposition, catheter-related thrombosis, phlebitis, accidental removal, and shorter catheter lifespan. While IPC users experienced fewer of these issues, local insertion site infection duration and costs were comparable between the two groups. However, the limited sample sizes in seven of the 31 studies included, and the small number of studies contributing to some comparisons, warrants cautious interpretation of these results.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-12-30
DOI
https://doi.org/10.5281/zenodo.18348387
Primary Topic
Central Venous Catheters and Hemodialysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative meta-analysis of complications in implantable port catheters versus peripherally inserted central catheters in chemotherapy-treated cancer patients

Abdullah Alhammad Hussain Ali, Saeed Alharthi Manal khaled, A. Ajeebi Jawaher, Q. Alruwely Wajin Rubayyi et al.
Zenodo (CERN European Organization for Nuclear Research)
Central Venous Catheters and Hemodialysis
article

Comparative meta-analysis of complications in implantable port catheters versus peripherally inserted central catheters in chemotherapy-treated cancer patients

Abdullah Alhammad Hussain Ali, Saeed Alharthi Manal khaled, A. Ajeebi Jawaher, Q. Alruwely Wajin Rubayyi, Alzahrani Ghada Attaih, Abdullah Alamri Waad Mohammed, Sami Altalhi Bayan, S. Imam Mohamed, Sultan Alosaimi Raghad, Abuayfah Hawra Redha, Alotaibi Khalid Sinhat, Almuthaybiri Nasser Mutiq, Abdullah Alshareef Faisal Abdulaziz, Saad Alosaimi Layan Wadea, Saud Alotaibi Abdulaziz Jameel
article en

Abstract

Background and objectives: A meta-analysis compared complications associated with Peripherally Inserted Central Catheters (PICCs) and Implanted Port Catheters (IPCs) in cancer patients undergoing chemotherapy. Methods: A comprehensive literature search up to December 2024, involving 12,587 participants, was analyzed using pooled Odds Ratios (ORs) and Mean Differences (MDs) with 95% Confidence Intervals (CIs). Dichotomous and continuous outcome measures were evaluated via random-effects or fixed-effects models. Results: Results revealed that PICC use was linked to significantly elevated risks of occlusion (OR 4.39; 95% CI 2.95-6.52, p<0.001), catheter-related infections (OR 2.42; 95% CI 1.34-4.36, p=0.003), malposition (OR 7.39; 95% CI 3.52-15.50, p><0.001), thrombosis (OR 2.88; 95% CI 2.05-4.05, p><0.001), phlebitis (OR 6.41; 95% CI 2.90-14.14, p><0.001), and accidental removal (OR 3.38; 95% > <0.001), catheter-related infections (OR 2.42; 95% CI 1.34-4.36, p=0.003), malposition (OR 7.39; 95% CI 3.52-15.50, p<0.001), > <0.001), thrombosis (OR 2.88; 95% CI 2.05-4.05, p<0.001), phlebitis (OR 6.41; 95% CI 2.90-14.14, p<0.001), and accidental removal (OR 3.38; 95% CI 1.97-5.81, p<0.001), alongside a notably shorter indwelling duration (MD -233.16 days; 95% CI -449.52 to -16.80, p=0.03) compared to IPC. However, no significant differences were found in puncture-site local infection rates (OR 1.79; 95% CI 0.88-3.64, p=0.11) or cost (MD -394.02; 95% CI -882.19 to 94.14, p=0.11) between the two devices. Conclusion: Patients with PICCs experienced significantly more complications than those with IPCs, especially cancer patients undergoing chemotherapy. These complications included occlusions, catheter-related infections, malposition, catheter-related thrombosis, phlebitis, accidental removal, and shorter catheter lifespan. While IPC users experienced fewer of these issues, local insertion site infection duration and costs were comparable between the two groups. However, the limited sample sizes in seven of the 31 studies included, and the small number of studies contributing to some comparisons, warrants cautious interpretation of these results.

Zenodo (CERN European Organization for Nuclear Research)
Yanbu University College (SA), Taif University (SA), Shaqra University (SA), King Faisal Specialist Hospital & Research Centre (SA), Riyadh Elm University (SA), Ministry of Health (AE), Imam Abdulrahman Bin Faisal University (SA), King Khalid University (SA), Jazan University (SA)
Good health and well-being
Openalex Percentile: Top 21%
Central Venous Catheters and Hemodialysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.